By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fox Chase Cancer Center in Philadelphia said today that it will partner with Life Technologies to develop, use, and evaluate the use of next-generation clinical sequencing technologies for personalized cancer care.

The partnership will be a cornerstone for the planned Cancer Genome Institute at Fox Chase, which aims to combine multidisciplinary resources at the center to evaluate how genomic sequencing of tumors can be used to manage cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.